(Q67720610)

English

Effects of bacillus calmette-guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer

scientific article published on January 15, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728384%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728384%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Effects of bacillus calmette-guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer (English)

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

1 reference

based on heuristic

inferred from title

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

author name string

Y. Mizutani

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728384

10 November 2022

Y. Nio

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728384

10 November 2022

M. Fukumoto

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728384

10 November 2022

O. Yoshida

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728384

10 November 2022

language of work or name

0 references

publication date

1 January 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728384%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

15 January 1992

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1728384

10 November 2022

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728384%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

69

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728384%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728384%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

537-545

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728384%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/IJC.2910170504

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

1

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Histopathology of BCG and thiotepa treated bladders

3

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Journal of the National Cancer Institute

5

49

119

author name string

Zbar

publication date

1972

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: lack of a role of natural killer cells

6

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses

7

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin

8

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Experience with bacillus Calmette-Guérin in patients with superficial bladder tumors. Value of monocyte activation in intravesical bacillus Calmette-Guérin therapy

10

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG

11

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Urinary interleukins in patients receiving intravesical Bacillus Calmette-Guerin therapy for superficial bladder cancer

12

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Immune surveillance revisited

13

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity

14

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Natural Cell-Mediated Immunity

15

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo

16

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Journal of the National Cancer Institute

17

48

1441

author name string

Hanna

publication date

1972

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

BCG induced murine peritoneal exudate cells: cytotoxic activity against a syngeneic bladder tumor cell line

18

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

22

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma

23

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin

27

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3

28

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells

30

1 reference

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19920115)69:2%3C537::AID-CNCR2820690242%3E3.0.CO;2-3

10 November 2022

Identifiers

10.1002/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728384%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728384%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67720610&oldid=1768339739"